Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD AND MARKER FOR THE INDIVIDUAL PROGNOSIS AND/OR THE INDIVIDUAL DETECTION OF NEUROPATHY
Document Type and Number:
WIPO Patent Application WO/2011/003623
Kind Code:
A3
Abstract:
The present invention relates to a method for the individual prognosis of the occurrence and/or the progression of neuropathy and/or for the individual diagnosis of neuropathy in a mammal, in particular in a human being. It further relates to markers suited for said purpose and to uses of said markers.

Inventors:
SEREDA MICHAEL (DE)
FLEDRICH ROBERT (DE)
ROSSNER MORITZ (DE)
WICHERT SVEN (DE)
NAVE KLAUS ARMIN (DE)
Application Number:
PCT/EP2010/004197
Publication Date:
May 05, 2011
Filing Date:
July 09, 2010
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MAX PLANCK GESELLSCHAFT (DE)
SEREDA MICHAEL (DE)
FLEDRICH ROBERT (DE)
ROSSNER MORITZ (DE)
WICHERT SVEN (DE)
NAVE KLAUS ARMIN (DE)
International Classes:
G01N33/68; C12Q1/68
Domestic Patent References:
WO2005049866A22005-06-02
Foreign References:
US20070059357A12007-03-15
US20050208544A12005-09-22
Other References:
SANDHU H S ET AL: "Measurement of circulating neuron-specific enolase mRNA in diabetes mellitus.", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES AUG 2008 LNKD- PUBMED:18837957, vol. 1137, August 2008 (2008-08-01), pages 258 - 263, XP002610835, ISSN: 1749-6632
DATABASE ncbi [online] 28 June 2009 (2009-06-28), "Homo sapiens adiponectin and collagen domain containing (ADIPOQ), mRNA", XP002610836, retrieved from ncbi accession no. NCBI:NM_004797.2 Database accession no. NM_004797.2
KATO KENICHI ET AL: "Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.", CLINICAL ENDOCRINOLOGY MAR 2008 LNKD- PUBMED:17970779, vol. 68, no. 3, March 2008 (2008-03-01), pages 442 - 449, XP002610837, ISSN: 1365-2265
Attorney, Agent or Firm:
PFENNING, MEINIG & PARTNER GBR (Theresienhöhe 13, München, DE)
Download PDF: